THE IMPORTANCE OF CHOOSING THE RIGHT DRUG AND RIGHT INHALER DEVICE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Abstract

The main treatment of chronic obstructive pulmonary disease is inhaled bronchodilators. Clinical trials showed and proved long-acting anti-muscarines (LAMA) and long-acting β2 agonists (LABA) are both more effective than regular short-acting drugs. Complementary pharmacological profiles of tiotropium and olodaterol and data from studies of double
therapy showed that these medicinal products effectively supplement each other. Combined LAMA LABA therapy increases the general therapeutic benefit. However, choosing the right inhaler is very important in addition to an effective combination of drugs. Respimat® soft mist inhaler is a unique device that delivers extremely high deposition of drug particles even in the smallest airways, compared to other devices.